Skip to main content

Table 1 Characteristics of the selected studies included in the systematic review and network meta-analysis

From: Four kinds of traditional Chinese exercise therapy in the treatment of type 2 diabetes: a systematic review and network meta-analysis

Author (year)

TG

CG

Treatment cycle

Outcome indicatorsa

Sample size

Age (years)

Treatment measures

Sample size

Age (years)

Treatment measures

Kan (2004)

26

52 ± 6.7

T

22

52 ± 6.7

N

12

Zhang (2008)

10

57.4 ± 6.2

T

9

57.4 ± 6.2

N

14

Wu (2010)

20

51.3 ± 7.9

T

20

52.4 ± 5.5

N

24

Chen (2010)

50

56.1 ± 6.2

T

44

57.4 ± 5.8

N

12

Ji (2012)

32

60.31 ± 7.23

B

30

60.26 ± 7.15

N

8

Sununta (2013)

32

35 ± 5.63

T

32

36.16 ± 4.48

N

12

Li (2013)

30

57.3 ± 10.3

T

30

57.3 ± 10.3

N

8

Li (2013)

54

54.21 ± 9.47

T

54

50.42 ± 9.68

B

12

Meng (2014)

100

68.4 ± 3.2

T

100

68.4 ± 3.2

N

12

Li (2015)

50

62.91 ± 2.48

T

50

63.27 ± 2.86

N

24

Shen (2019)

54

67.8 ± 5.1

T

54

66.2 ± 4.6

N

12

Zhou (2020)

46

53.1

T

47

53.1

N

8

Li (2020)

40

45–75

W

40

45–75

N

4

Wang (2007)

40

57.8 ± 7.5

B

39

56.5 ± 6.9

N

24

Pan (2008)

24

47 ± 7

B

24

45 ± 9

N

24

Lin (2009)

24

59.38 ± 5.29

B

23

55.30 ± 8.67

N

16

Li (2009)

40

57.8 ± 7.5

B

39

56.5 ± 6.9

N

24

Huang (2011)

30

57.8 ± 7.5

B

30

56.5 ± 6.9

N

24

Zhou (2011)

61

67.4 ± 9.23

B

61

68.13 ± 10.64

N

12

Guan (2012)

39

59.20 ± 8.80

B

40

58.70 ± 8.30

N

16

Duan (2012)

100

47 ± 7

B

100

45 ± 9

N

8

Wang (2015)

30

61.7 ± 6.9

B

30

61.3 ± 8.4

N

6

Wu (2015)

20

63.9 ± 7.6

B

20

65.3 ± 6.0

N

12

Li (2016)

30

60 ± 3

B

30

59 ± 4

N

12

Li (2017)

43

44.32 ± 5.07

B

43

42.91 ± 6.10

N

12

Wu (2019)

30

57.8 ± 7.5

B

30

56.5 ± 6.9

N

12

He (2019)

24

51.83 ± 14.32

B

24

51.59 ± 11.46

N

48

Li (2020)

60

57.42 ± 5.55

B

55

58.89 ± 5.22

N

24

Meng (2017)

12

40 ~ 60

Y

12

40 ~ 60

N

12

Lu (2022)

60

66.5 ± 3.68

Y

60

67.17 ± 2.86

N

12

Hu (2022)

30

61.45 ± 4.97

T

30

59.55 ± 6.19

N

12

Zhou (2021)

33

62.12 ± 7.59

T

33

60.91 ± 6.99

N

24

Qi (2021)

40

41–69

B

40

40–70

N

24

  1. TG treatment group, CG control, T Taijiquan, B Baduanjin, W Wuqinxi, Y Yijinjing, N no traditional exercise intervention
  2. a FBG; TG; TC; LDL-C; HDL-C; HbAlc; ISI; 2hPG